Richard J Kim is President US Comm & Strat Mktg of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 19,770 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Jan 01, 2021, when has been sold 259 shares (Common Stock) at a price of $24.7 per share, resulting in proceeds of $6,397. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.8K
0% 3M change
0% 12M change
Total Value Held $0

Richard J Kim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2021
SELL
Payment of exercise price or tax liability
$6,397 $24.7 p/Share
259 Reduced 1.29%
19,770 Common Stock
Dec 31 2020
SELL
Payment of exercise price or tax liability
$19,735 $24.7 p/Share
799 Reduced 3.84%
20,029 Common Stock
Oct 01 2020
SELL
Payment of exercise price or tax liability
$9,384 $42.08 p/Share
223 Reduced 1.06%
20,828 Common Stock

Also insider at

AVDL
AVADEL PHARMACEUTICALS PLC Healthcare
RJK

Richard J Kim

President US Comm & Strat Mktg
New York, NY

Track Institutional and Insider Activities on ICPT

Follow INTERCEPT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Track Activities on ICPT